Piramal Pharma Q4 Results

  • BSE: 543635
  • NSE: PPLPHARMA
  • ISIN: INE0DK501011
  • Sector: Biotechnology & Drugs
BSE
246.601.60 (0.65%)
Volume1.95 L
Updated: Tue 17 Nov, 2026 | 10:56:41
NSE
244.80-0.13 (-0.05%)
Volume1.91 M
Updated: Tue 17 Nov, 2026 | 10:42:20
Today: 239.05
247.75
52-Wk: 132.50
253.85

Q4 Results Highlights

Quarter ended Mar 26

    Note: Comparison is on QoQ basis

    Quarterly - Piramal Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 26Dec 25QoQ CompMar 24YoY Comp
    Total Operating Expense 2,685.422,197.9922.18%1,740.7110.25%
    Depreciation/ Amortization 218.38212.742.65%196.13-10.04%
    Operating Income 66.35-58.120.00%811.65-79.15%
    Net Income -8.83-,136.19-93.52%101.270.00%
    Other Operating Expenses Total 649.57557.9816.41%-26.383.75%
    Net Income Before Taxes 43.00-93.860.00%227.48-84.24%
    Total Revenue 2,751.772,139.8728.60%2,552.36-0.08%
    Selling/ General/ Admin Expenses Total 586.02599.85-2.31%526.05-4.25%
    Diluted Normalized EPS 0.80-0.830.00%0.86-30.25%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market